MBX Biosciences, Inc. (MBX) KPIs and segments

MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$55.94+1.43 (+2.62%)

Close on Nov 13, 2026Market cap $2.69BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive MBX Biosciences's business

Coming soon

This tab will track the numbers specific to MBX Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?